CRIS

Permanent URI for this communityhttps://investigadores.udd.cl/handle/123456789/1

Browse

Settings

Author: search.filters.author.María Isabel JercicHas files: No

Search Results

Now showing 1 - 2 of 2
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Item type:Publication,
    Human Infection by Zoonotic Eye Fluke
    <i>Philophthalmus lacrymosus</i>
    , South America
    (Centers for Disease Control and Prevention (CDC), 2025-12)
    WEITZEL, THOMAS  
    ;
    Esteban M. Cordero
    ;
    Trinidad Mujica
    ;
    Carolina Aravena
    ;
    Brianne E. Phillips
      1
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Item type:Publication,
    Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile
    (2021)
    Stella M. Chenet
    ;
    Alan Oyarce
    ;
    Jorge Fernandez
    ;
    Rafael Tapia-Limonchi
    ;
    WEITZEL, THOMAS  
    <jats:title>ABSTRACT</jats:title><jats:p>In November 2018, we diagnosed a cluster of falciparum malaria cases in three Chilean travelers returning from Nigeria. Two patients were treated with sequential intravenous artesunate plus oral atovaquone/proguanil (AP) and one with oral AP. The third patient, a 23-year-old man, presented with fever on day 29 after oral AP treatment and was diagnosed with recrudescent falciparum malaria. The patient was then treated with oral mefloquine, followed by clinical recovery and resolution of parasitemia. Analysis of day 0 and follow-up blood samples, collected on days 9, 29, 34, 64, and 83, revealed that parasitemia had initially decreased but then increased on day 29. Sequencing confirmed Tyr268Cys mutation in the <jats:italic>cytochrome b</jats:italic> gene, associated with atovaquone resistance, in isolates collected on days 29 and 34 and <jats:italic>P. falciparum dihydrofolate reductase</jats:italic> mutation Asn51Ile, associated with proguanil resistance in all successfully sequenced samples. Molecular characterization of imported malaria contributes to clinical management in non-endemic countries, helps ascertain the appropriateness of antimalarial treatment policies, and contributes to the reporting of drug resistance patterns from endemic regions.</jats:p>
      4Scopus© Citations 5